Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer Database.

Peacker BL; Thompson BB; Behbahani S; Corey S; Braun N; Baker NM; El-Banna G; Jain S; Barnes J; Patel C; Ma KS; Chen ST

doi:10.1016/j.jaad.2025.11.052

← 뒤로

Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer Database.

Journal of the American Academy of Dermatology 2026 Vol.94(3) p. 1008-1010

Peacker BL, Thompson BB, Behbahani S, Corey S, Braun N, Baker NM, El-Banna G, Jain S, Barnes J, Patel C, Ma KS, Chen ST

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Peacker BL, Thompson BB, et al. (2026). Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer Database.. Journal of the American Academy of Dermatology, 94(3), 1008-1010. https://doi.org/10.1016/j.jaad.2025.11.052

MLA Peacker BL, et al.. "Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer Database.." Journal of the American Academy of Dermatology, vol. 94, no. 3, 2026, pp. 1008-1010.

PMID 41276125

DOI 10.1016/j.jaad.2025.11.052

같은 제1저자의 인용 많은 논문 (1)

Immunotherapy for Melanoma in Patients with Altered Immune Systems: Unique Challenges and Clinical Considerations.
Advances in therapy 2026